홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Methyl 2-(5-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-(3-bromophenyl)-7-methylimidazo[1,2-a]pyridin-6-yl)-2-oxoacetate → Methyl 2-(5-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-(3-bromophenyl)-7,8-dimethylimidazo[1,2-a]pyridin-6-yl)-2-oxoacetate

HRID 1482065
노트
인쇄 미리보기

반응식

HRID 1482065 반응식
[Br:1][C:2]1[CH:3]=[C:4]([C:8]2[N:9]=[C:10]3[C:15]([CH3:16])=[C:14]([CH3:17])[C:13]([C:18](=[O:23])[C:19]([O:21][CH3:22])=[O:20])=[C:12](Cl)[N:11]3[CH:25]=2)[CH:5]=[CH:6][CH:7]=1.[CH2:26]([O:29][C:30]1([CH3:59])[CH2:35][CH2:34][N:33](C2N3C=C(C4C=CC=C(Br)C=4)N=C3C=C(C)C=2C(=O)C(OC)=O)[CH2:32][CH2:31]1)[CH:27]=[CH2:28]>>[CH2:26]([O:29][C:30]1([CH3:59])[CH2:31][CH2:32][N:33]([C:12]2[N:11]3[CH:25]=[C:8]([C:4]4[CH:5]=[CH:6][CH:7]=[C:2]([Br:1])[CH:3]=4)[N:9]=[C:10]3[C:15]([CH3:16])=[C:14]([CH3:17])[C:13]=2[C:18](=[O:23])[C:19]([O:21][CH3:22])=[O:20])[CH2:34][CH2:35]1)[CH:27]=[CH2:28]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 118308795Methyl 2-(5-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-(3-bromophenyl)-7-methylimidazo[1,2-a]pyridin-6-yl)-2-oxoacetateHCID 118308831Methyl 2-(2-(3-bromophenyl)-5-chloro-7,8-dimethylimidazo[1,2-a]pyridin-6-yl)-2-oxoacetate

생성물 1

HCID 118308848Methyl 2-(5-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-(3-bromophenyl)-7,8-dimethylimidazo[1,2-a]pyridin-6-yl)-2-oxoacetate수율 60%

실험 절차

Prepared from methyl 2-(2-(3-bromophenyl)-5-chloro-7,8-dimethylimidazo[1,2-a]pyridin-6-yl)-2-oxoacetate in 60% yield following the same procedure as methyl 2-(5-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-(3-bromophenyl)-7-methylimidazo[1,2-a]pyridin-6-yl)-2-oxoacetate. LCMS (ESI, M+1): 540.20.

출처 및 근거

ORD 기록
ord-d2ca2d0cbd6c4c0ba76179dc1e73e155
출처 데이터셋
uspto-grants-2016_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09409922B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트